Phosphatases maintain low catalytic activity of SGK1: DNA damage resets the balance in favor of phosphorylation

The Serum- and Glucocorticoid-induced Kinase 1 (SGK1) promotes cell survival under stress conditions and facilitates the emergence of drug resistance in Cancer. The underlying mechanisms of these observations are not fully understood. In this study, we found that SGK1 activity is suppressed by the action of the S/T phosphatases PP5 and PP2A, which constantly dephosphorylate SGK1. Using newly developed anti-phosphor SGK1 Antibodies and inhibitors of phosphatases, we determined that the high degree of dephosphorylation is caused by two factors: the tendency of SGK1 to unfold, which makes it dependent on HSP90 chaperone complexes composed of four proteins, HSP90/CDC37/PP5/SGK1, and where the Phosphatase PP5 persistently dephosphorylates SGK1 within the complex. SGK1 binding to PP2A regulatory subunits B55γ and B55δ brings PP2A catalytic subunit close to exposed SGK1 phosphoresidues. A further association of phosphorylated pS37-FAM122A -an endogenous inhibitor of PP2A- to the holoenzyme diminishes dephosphorylation of SGK1 mediated by PP2A. Our study also reveals that genotoxic stress can reverse the dominant impact of phosphatases over kinases by activating the DNA-dependent protein kinase (DNA-PK), which enhances mTORC2 activity directed to SGK1. Thus, our results provide insight into a molecular pathway that enables SGK1 to gain phosphorylation and catalytic activity, and promote cell survival, potentially diminishing the efficacy of Cancer treatments. As the DNA damage response operates in many Cancer cells and is further induced by chemotherapies, the findings of this study could have significant implications for the development of novel Cancer therapies targeting SGK1.

DNA-PK; FAM122A; PP2A; PP5; genotoxicity; phosphorylation.